GeoVax Labs shares are trading higher after Noble Capital Markets maintained an Outperform rating on the stock and raised its price target from $6 to $10.
Portfolio Pulse from Benzinga Newsdesk
GeoVax Labs shares rose after Noble Capital Markets maintained an Outperform rating and increased the price target from $6 to $10.
August 19, 2024 | 2:47 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
GeoVax Labs shares increased following Noble Capital Markets' decision to maintain an Outperform rating and raise the price target from $6 to $10.
The increase in price target from $6 to $10 by Noble Capital Markets, along with the maintained Outperform rating, is a positive signal to investors, likely leading to increased buying interest and a short-term rise in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100